Glabridin alleviates inflammation and nociception in rodents by activating BKCa channels and reducing NO levels


Creative Commons License

Parlar A., ARSLAN S. O., Çam S. A.

Biological and Pharmaceutical Bulletin, vol.43, no.5, pp.884-897, 2020 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 43 Issue: 5
  • Publication Date: 2020
  • Doi Number: 10.1248/bpb.b20-00038
  • Journal Name: Biological and Pharmaceutical Bulletin
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Agricultural & Environmental Science Database, BIOSIS, CAB Abstracts, Chemical Abstracts Core, Chimica, EMBASE, MEDLINE, Veterinary Science Database
  • Page Numbers: pp.884-897
  • Keywords: Glabridin, nociception, inflammation, large conductance Ca++-activated K+, N(omega)-nitro-L-aginine methyl ester, transient receptor potential cation channel subfamily vanilloid 1, FORMALIN TEST, RAT MODEL, LICORICE, INHIBITION, CYTOKINE, MORPHINE, ACID, ANTINOCICEPTION, INVOLVEMENT, ANTIOXIDANT
  • Ankara University Affiliated: Yes

Abstract

© 2020 The Pharmaceutical Society of JapanInflammation, and the pain that accompanies it, is a natural response of the body. The licorice plant (Glycyrrhiza glabra) have demonstrated anti-inflammatory, anti-edematous, and anti-nociceptive effects of its extracts. The effective ingredient remains unidentified; however, one possibility is the unique isoflavone glabridin. The anti-nociceptive, and anti-inflammatory effects of glabridin and its possible mechanism with focus on the large conductance Ca2+-activated K+ (BKCa) channels and L-arginine-nitric oxide (NO) pathway were examined by using different tests. In order to determine the anti-edematous, anti-nociceptive, and anti-oxidative effects of glabradin, some tests such as the tail flick, hotplate, carrageenan-induced paw edema, air pouch, acetic-acid-induced writhing, formalin, and capsaicin tests, as well as toxicity and open field tests were made. Glabridin was administered to rats (n=8) or mice (n=8) for 3d at 3 doses (10, 20, and 40mg/kg). Glabridin inhibited cytokine production and showed an anti-nociceptive response via the activating of BKCa channels and downregulating NO level and partially transient receptor potential vanilloid-1 pathways. It also demonstrated anti-inflammatory effects by inhibiting cyclooxygenase (COX) activity, while showing no cytotoxicity. Glabridin, however, showed no anti-nociceptive effect in the neurogenic phase. Glabridin is a promising substance in terms of its anti-nociceptive and anti-inflammatory effects by disrupting peripheral NO production, inhibiting cyclic guanosine monophosphate (cGMP) activation and activating BKCa channels and its lack of acute and subacute toxic effects.